Standard Imaging’s Adaptivo software tracks and reports the dosimetric impact of changes in patient anatomy and positioning during the course of radiation treatment
Read article: Dosimetry software captures daily, cumulative patient trends
Motion synchronization, adaptive planning and treatment versatility will unlock the full potential of hypofractionated radiotherapy for value-based cancer care
Read article: Hypofractionation: a new value proposition in radiation oncology
The PERTAIN trial is examining the impact of FDG PET/CT-guided chemoradiotherapy for lung cancer patients in low- and middle-income countries
Read article: PET/CT-guided chemoradiotherapy improves lung cancer outcomes
A $2.03 million grant will help researchers develop optical technologies to monitor treatment response during head-and-neck cancer therapy
Read article: Optical imaging to monitor cancer response early in the treatment process
Auto-generated radiotherapy plans reduce plan preparation time, decrease plan variation and improve healthy tissue sparing
Read article: Automated radiotherapy planning benefits clinicians and patients
A round-up of some recent international patent applications in radiation therapy
Read article: Innovation: patent applications review
Could irradiation at ultrahigh dose rates provide the next leap forward in cancer therapy?
Read article: FLASH radiotherapy: from preclinical promise to the first human treatment
Avoiding neuroinflammation caused by conventional dose-rate irradiation is key to minimizing brain damage in ultrarapid FLASH radiotherapy in mice
Read article: Instantaneous brain irradiation limits cognitive impairment
The winners of AAPM's 2019 Young Investigator award presented their research on brachytherapy needle guidance, blood cell dose during radiotherapy and heart segmentation
Read article: Young investigators focus on brachytherapy, dose modelling and deep learning
Two studies reveal the potential of combining ablative radiotherapy with immunotherapy in patients with non-small cell lung cancer
Read article: Immunotherapy plus radiotherapy benefits metastatic lung cancer patients
